Zhi Hong Chen
Director/Board Member chez Shanghai Neutan Pharmaceutical Co., Ltd.
Postes actifs de Zhi Hong Chen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Shanghai Neutan Pharmaceutical Co., Ltd.
 Shanghai Neutan Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Shanghai Neutan Pharmaceutical Co., Ltd. provides synthetic chemistry and customization services. Shanghai Neutan Pharmaceutical Co. is a national high-tech enterprise and a one-stop full-process innovative drug CDMO platform. The company is based in Shanghai, China. The Chinese company has established a complete quality assurance system that complies with domestic and international GMP standards. The company offers high-quality CMC, clinical samples, and commercial products. The company's business scope includes pre-clinical CRO, new drug discovery FTE, CMC, new drug discovery FFS, CXO, etc. The company was founded in 2019 by Xue Jun Liu, and the CEO is Xiao Dong Chen. | Director/Board Member | - | - |
Historique de carrière de Zhi Hong Chen
Anciens postes connus de Zhi Hong Chen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD | Director/Board Member | - | - |
| Chief Executive Officer | - | - |
Statistiques
Internationale
| Chine | 3 |
Opérationnelle
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD | Health Technology |
| Entreprise privées | 1 |
|---|---|
Shanghai Neutan Pharmaceutical Co., Ltd.
Shanghai Neutan Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Shanghai Neutan Pharmaceutical Co., Ltd. provides synthetic chemistry and customization services. Shanghai Neutan Pharmaceutical Co. is a national high-tech enterprise and a one-stop full-process innovative drug CDMO platform. The company is based in Shanghai, China. The Chinese company has established a complete quality assurance system that complies with domestic and international GMP standards. The company offers high-quality CMC, clinical samples, and commercial products. The company's business scope includes pre-clinical CRO, new drug discovery FTE, CMC, new drug discovery FFS, CXO, etc. The company was founded in 2019 by Xue Jun Liu, and the CEO is Xiao Dong Chen. | Health Technology |
- Bourse
- Insiders
- Zhi Hong Chen
- Expérience
